Assessing Zimmer Biomet Holdings: Insights From 8 Financial Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, 8 analysts have evaluated Zimmer Biomet Holdings (NYSE:ZBH), with a mix of bullish, indifferent, and somewhat bearish ratings. The average 12-month price target has decreased by 6.39% to $123.88. Recent analyst actions predominantly involve lowering ratings and price targets.
August 08, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have mixed views on Zimmer Biomet Holdings, with recent actions predominantly lowering ratings and price targets. The average 12-month price target has decreased by 6.39% to $123.88.
The majority of analysts have lowered their ratings and price targets for Zimmer Biomet Holdings, indicating a bearish sentiment. This is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100